Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, today announced that ...
American Association of Individual Investors3 天
Why Lineage Cell Therapeutics, Inc.’s (LCTX) Stock Is Up 14.78%
Lineage Cell Therapeutics, Inc.’s LCTX share price has surged by 14.78%, which has investors questioning if this is right time to sell.